Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Queensland Health
Daiichi Sankyo
Covington
Citi

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 7,576,053

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,576,053
Title:Methods and compositions for treating degenerative bone disorders
Abstract: The present disclosure provides methods and compositions using Syk inhibitory compounds for treating degenerative bone disorders and as prophylactic treatment to prevent bone loss. These treatments may reduce the fracture risk associated with bone loss and compromised bone strength.
Inventor(s): Masuda; Esteban (Menlo Park, CA), Pine; Polly (Los Altos, CA)
Assignee: Rigel Pharmaceuticals, Inc. (South San Francisco, CA)
Application Number:11/452,767
Patent Claims:see list of patent claims

Details for Patent 7,576,053

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23 ➤ Try a Free Trial Rigel Pharmaceuticals, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ➤ Try a Free Trial Rigel Pharmaceuticals, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ➤ Try a Free Trial Rigel Pharmaceuticals, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23 ➤ Try a Free Trial Rigel Pharmaceuticals, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,576,053

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2006135915 Dec 21, 2006
World Intellectual Property Organization (WIPO) 2006135915 Mar 08, 2007
United States of America 2007004626 Jan 04, 2007
Japan 2008543855 Dec 04, 2008
Japan 2013231064 Nov 14, 2013
European Patent Office 1896134 Mar 12, 2008
Canada 2607901 Aug 16, 2016
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Covington
Daiichi Sankyo
Argus Health
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.